NYXH — Nyxoah SA Share News
0.000.00%
- €82.08m
- €52.26m
- €10.02m
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer
Brief: Nyxoah Announces Chief Financial Officer Transition
Brief: Nyxoah Announces Acccess U.S. Pivotal Study Meets Primary Safety And Efficacy Endpoints In Complete Concentric Collapse Patients
Nyxoah Q2 revenue surges on U.S. growth, but margins drop
Brief: Nyxoah SA Q2 EPS EUR -0.578
Brief: Nyxoah Receives $15 Million From The European Investment Bank
French and Benelux stocks-Factors to watch
Medical device co Nyxoah plunges on $95 mln share sale amid US CEO search
NASDAQ RESUMED AT 11:45 AM
Brief: Nyxoah Prices 55.23 Million Ordinary Shares At $1.72 Per Share In Public Offering
Medical device co Nyxoah plunges after launching stock offering, US CEO search
Medical device co Nyxoah plunges on stock offering
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:51 AM
Brief: Nyxoah Announces Offering Of Ordinary Shares
Brief: Nyxoah To Transition Leadership To US-Based CEO
Brief: Nyxoah Reports First Quarter 2026 Financial And Operating Results